| Kadima Rehabilitation & Nursing At Lititz | |
| 125 South Broad Street, Lititz, Pennsylvania 17543 | |
| (717) 626-0211 | |
| Name | Kadima Rehabilitation & Nursing At Lititz |
|---|---|
| Location | 125 South Broad Street, Lititz, Pennsylvania |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 42 |
| Occupancy Rate | 82.86% |
| Medicare ID (CCN) | 395590 |
| Legal Business Name | Lititz Rehabilitation Nursing Llc |
| Ownership Type | For Profit - Partnership |
| NPI Number | 1255329645 |
| Organization Name | LANCASTER LEASING PARTNERSHIP |
| Doing Business As | AUDUBON VILLA NURSING HOME |
| Address | 125 S Broad St, Lititz, PA 17543 |
| Phone Number | 717-626-0211 |
News Archive
A newly conservative Supreme Court agreed to hear a case most assumed it would use to overrule the 1973 landmark abortion-rights ruling, Roe v. Wade. And Democrats on Capitol Hill, convinced the issue would play to their political favor, vowed to bring up legislation that would write abortion protections into federal law.
Individuals with a gambling problem are at increased risk for developing Axis I psychiatric disorders, results from a US study show.
Smiths Medical, a leading global medical device manufacturer, announced today it has received FDA 510(k) clearance to market its CADD-Solis pain management system version 3.0 with Programmed Intermittent Bolus and Patient Controlled Analgesics delivery in the United States. The new customizable, infusion system will help healthcare providers overcome challenges in maintaining effective epidural analgesia during labor and delivery or with post-operative pain management.
FUJIFILM Medical Systems U.S.A., Inc. announced the availability of Synapse Mobility 3.0, a new zero footprint application with improved features that enable access to Fujifilm's suite of Synapse products from hand-held mobile devices, as well as Macintosh- or Windows-based PCs.
Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan.
› Verified 5 days ago
| NPI Number | 1316308968 |
| Organization Name | MAYBROOK-P AUDUBON OPCO, LLC |
| Doing Business As | THE GARDENS AT LITITZ |
| Address | 125 S Broad St, Lititz, PA 17543 |
| Phone Number | 717-626-0211 |
News Archive
A newly conservative Supreme Court agreed to hear a case most assumed it would use to overrule the 1973 landmark abortion-rights ruling, Roe v. Wade. And Democrats on Capitol Hill, convinced the issue would play to their political favor, vowed to bring up legislation that would write abortion protections into federal law.
Individuals with a gambling problem are at increased risk for developing Axis I psychiatric disorders, results from a US study show.
Smiths Medical, a leading global medical device manufacturer, announced today it has received FDA 510(k) clearance to market its CADD-Solis pain management system version 3.0 with Programmed Intermittent Bolus and Patient Controlled Analgesics delivery in the United States. The new customizable, infusion system will help healthcare providers overcome challenges in maintaining effective epidural analgesia during labor and delivery or with post-operative pain management.
FUJIFILM Medical Systems U.S.A., Inc. announced the availability of Synapse Mobility 3.0, a new zero footprint application with improved features that enable access to Fujifilm's suite of Synapse products from hand-held mobile devices, as well as Macintosh- or Windows-based PCs.
Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan.
› Verified 5 days ago
| NPI Number | 1922590603 |
| Organization Name | LITITZ REHABILITATION & NURSING LLC |
| Doing Business As | KADIMA REHABILITATION & NURSING AT LITITZ |
| Address | 125 S Broad St, Lititz, PA 17543 |
| Phone Number | 717-626-0211 |
News Archive
A newly conservative Supreme Court agreed to hear a case most assumed it would use to overrule the 1973 landmark abortion-rights ruling, Roe v. Wade. And Democrats on Capitol Hill, convinced the issue would play to their political favor, vowed to bring up legislation that would write abortion protections into federal law.
Individuals with a gambling problem are at increased risk for developing Axis I psychiatric disorders, results from a US study show.
Smiths Medical, a leading global medical device manufacturer, announced today it has received FDA 510(k) clearance to market its CADD-Solis pain management system version 3.0 with Programmed Intermittent Bolus and Patient Controlled Analgesics delivery in the United States. The new customizable, infusion system will help healthcare providers overcome challenges in maintaining effective epidural analgesia during labor and delivery or with post-operative pain management.
FUJIFILM Medical Systems U.S.A., Inc. announced the availability of Synapse Mobility 3.0, a new zero footprint application with improved features that enable access to Fujifilm's suite of Synapse products from hand-held mobile devices, as well as Macintosh- or Windows-based PCs.
Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A newly conservative Supreme Court agreed to hear a case most assumed it would use to overrule the 1973 landmark abortion-rights ruling, Roe v. Wade. And Democrats on Capitol Hill, convinced the issue would play to their political favor, vowed to bring up legislation that would write abortion protections into federal law.
Individuals with a gambling problem are at increased risk for developing Axis I psychiatric disorders, results from a US study show.
Smiths Medical, a leading global medical device manufacturer, announced today it has received FDA 510(k) clearance to market its CADD-Solis pain management system version 3.0 with Programmed Intermittent Bolus and Patient Controlled Analgesics delivery in the United States. The new customizable, infusion system will help healthcare providers overcome challenges in maintaining effective epidural analgesia during labor and delivery or with post-operative pain management.
FUJIFILM Medical Systems U.S.A., Inc. announced the availability of Synapse Mobility 3.0, a new zero footprint application with improved features that enable access to Fujifilm's suite of Synapse products from hand-held mobile devices, as well as Macintosh- or Windows-based PCs.
Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 21.37 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 6.36 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 52.86 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.71 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.89 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.88 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.04 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 94.96 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 10.81 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 61.84 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.72 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 39.4 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 26.5 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 10.26 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 66.89 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 78.27 | 82.93 |
News Archive
A newly conservative Supreme Court agreed to hear a case most assumed it would use to overrule the 1973 landmark abortion-rights ruling, Roe v. Wade. And Democrats on Capitol Hill, convinced the issue would play to their political favor, vowed to bring up legislation that would write abortion protections into federal law.
Individuals with a gambling problem are at increased risk for developing Axis I psychiatric disorders, results from a US study show.
Smiths Medical, a leading global medical device manufacturer, announced today it has received FDA 510(k) clearance to market its CADD-Solis pain management system version 3.0 with Programmed Intermittent Bolus and Patient Controlled Analgesics delivery in the United States. The new customizable, infusion system will help healthcare providers overcome challenges in maintaining effective epidural analgesia during labor and delivery or with post-operative pain management.
FUJIFILM Medical Systems U.S.A., Inc. announced the availability of Synapse Mobility 3.0, a new zero footprint application with improved features that enable access to Fujifilm's suite of Synapse products from hand-held mobile devices, as well as Macintosh- or Windows-based PCs.
Onyx Pharmaceuticals, Inc. today announced that it has entered into an exclusive agreement with Ono Pharmaceutical Co., Ltd. to develop and commercialize two compounds from Onyx's proteasome inhibitor development program, carfilzomib and ONX 0912. Under the terms of the agreement, Ono has exclusive rights to develop and commercialize both compounds for all oncology indications in Japan.
› Verified 5 days ago
Kadima Rehabilitation & Nursing At Lititz Location: 125 South Broad Street, Lititz, Pennsylvania 17543 Phone: (717) 626-0211 | |
United Zion Retirement Communi Location: 722 Furnace Hill Pike, Lititz, Pennsylvania 17543 Phone: (717) 626-2071 | |